There is much more to this story than meets the eye Read this newsletter in its entirety ViralClear Spinoff and the Team Behind the Scenes Good day ev...
Potential Big Pharma Acquisition Target. Full Report Will Be Available Soon.
NASDAQ Biopharma Potential Value Opportunity Potential Big Pharma Acquisition Target Shares may be ready to run Good day everyone, These are turbulent...
Tiny float, recent R/S, Junior gold miner in the Cortez Trend, with all-star management (NASDAQ: USAU) News out today as well!
Our new alert is on FIRE up over 100% on day one, updated report USAU Releases Update on Copper King Project Gold prices are rising and gaining tracti...
Tiny Float Biopharma Stock Exhibiting Value and Paying a Stock Dividend Real Soon
Tiny Float Biopharma Stock Exhibiting Value Spherix is paying a stock dividend real soon Good day everyone, Today we are initiating coverage of Spheri...
Potential New Tech in Treatment of Disease
Good day everyone, As you know we cover many biotech stocks. We’ve talked about companies developing pharma products with big potential. We’ve talked ...
Traders News Source Remains One of The Most Sought After Small Cap Stock Newsletters. Over 1000% in Bookable Gains This Year so Far
Traders News Source Remains One of The Most Sought After Small Cap Stock Newsletters Over 1000% in Bookable Gains This Year so Far Updates and what to...
Biotech Stocks are Surging in 2020. Over 500% in Realistic Bookable Gains Since December 2019 for our Members!
Biotech Stocks are Surging in 2020 Good day everyone, Over 450% in realistic bookable gains since December 2019 for our members! We may have another b...
Recent news of a potential pandemic has given (NASDAQ: CTXR) even more credence with Mino-Lok
Could This Be the Hottest Biopharma Stock of 2020? CTXR’s lead product could be the enemy of infections. Good day everyone, We are continuing our cove...
Biopharma Company Looking Ready to Run, Full Report
Biopharma Company Ready to Run ATNM product picked for HIV clinical trial Good day everyone, Today we are revisiting a stock we covered a couple weeks...
(NASDAQ: GNPX) Now Crossing $2/share in Pre-Market Trading, Full Report
Genprex Makes Significant FDA Announcement (GNPX) After Hours close at $1.38/share / Volume 53.6M shares traded, on watch for continuation… Fast Track...